Cellumen to Collaborate with Mayo Foundation on Breast Cancer Patient Stratification | GenomeWeb
NEW YORK (GenomeWeb News) - Cellumen said today that it will collaborate with the Mayo Foundation for Medical Education and Research to apply the company’s cellular systems biology approach to breast cancer patient stratification.
 
Cellumen said that the goal of the project is to create a breast cancer patient profile test to help improve disease treatment and diagnosis.
 
"We are treating breast tumors as a 'system' within the breast cancer patient," said Cellumen's CEO, Lansing Taylor.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.